NL8301663A - Analogen van neurohypofysiaire hormonen met remmende eigenschappen. - Google Patents

Analogen van neurohypofysiaire hormonen met remmende eigenschappen. Download PDF

Info

Publication number: NL8301663A
Authority: NL; Netherlands
Prior art keywords: group; mixture; residue; solution; compound
Prior art date: 1982-05-10

Application number

NL8301663A

Other languages

English (en)

Dutch (nl)

Original Assignee

Ceskoslovenska Akademie Ved

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-05-10

Filing date

1983-05-10

Publication date

1983-12-01

1982-05-10 Priority claimed from CS823340A external-priority patent/CS226923B1/cs

1982-08-26 Priority claimed from CS620582A external-priority patent/CS229895B1/cs

1982-08-26 Priority claimed from CS620482A external-priority patent/CS229894B1/cs

1982-08-27 Priority claimed from CS627182A external-priority patent/CS230327B1/cs

1983-05-10 Application filed by Ceskoslovenska Akademie Ved filed Critical Ceskoslovenska Akademie Ved

1983-12-01 Publication of NL8301663A publication Critical patent/NL8301663A/nl

Links

229940088597 hormone Drugs 0.000 title claims description 11
239000005556 hormone Substances 0.000 title claims description 11
230000002401 inhibitory effect Effects 0.000 title claims description 10
229940024606 amino acid Drugs 0.000 claims description 13
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 12
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 12
150000001413 amino acids Chemical class 0.000 claims description 12
BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical group NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims description 9
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 2
239000004472 Lysine Substances 0.000 claims description 2
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
229960000310 isoleucine Drugs 0.000 claims description 2
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
125000003277 amino group Chemical group 0.000 claims 1
239000000709 neurohypophysis hormone Substances 0.000 claims 1
239000000825 pharmaceutical preparation Substances 0.000 claims 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 1
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
239000000203 mixture Substances 0.000 description 20
239000000243 solution Substances 0.000 description 20
150000001875 compounds Chemical class 0.000 description 19
229910052739 hydrogen Inorganic materials 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
239000000047 product Substances 0.000 description 12
238000004128 high performance liquid chromatography Methods 0.000 description 11
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 10
238000004458 analytical method Methods 0.000 description 10
238000004809 thin layer chromatography Methods 0.000 description 10
235000011054 acetic acid Nutrition 0.000 description 8
239000003112 inhibitor Substances 0.000 description 7
229960001723 oxytocin Drugs 0.000 description 7
FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 6
101800000989 Oxytocin Proteins 0.000 description 6
102400000050 Oxytocin Human genes 0.000 description 6
XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
230000000694 effects Effects 0.000 description 6
XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 6
125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
108090000765 processed proteins & peptides Proteins 0.000 description 5
MRNKEVGKBFIFET-AHCPCVRLSA-N (2s)-n-[(2s)-1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]-1-[(4s,7s,10s,16s)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-[(2s)-butan-2-yl]-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1-thia-5,8,11,14,17-pentazacycloicosane-4-carb Chemical compound C([C@H]1C(=O)NC(C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSCCC(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 MRNKEVGKBFIFET-AHCPCVRLSA-N 0.000 description 4
108700042417 deamino-6-carba- oxytocin Proteins 0.000 description 4
IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 4
229910000041 hydrogen chloride Inorganic materials 0.000 description 4
230000005923 long-lasting effect Effects 0.000 description 4
238000000034 method Methods 0.000 description 4
102000004196 processed proteins & peptides Human genes 0.000 description 4
239000002904 solvent Substances 0.000 description 4
CHNBIRCZIVMXKX-RYUDHWBXSA-N (2S)-N-(2-amino-2-oxoethyl)-2-[[(2S)-2-amino-4-sulfanylbutanoyl]-propylamino]-4-methylpentanamide Chemical compound N[C@@H](CCS)C(=O)N([C@@H](CC(C)C)C(=O)NCC(=O)N)CCC CHNBIRCZIVMXKX-RYUDHWBXSA-N 0.000 description 3
GXBMIBRIOWHPDT-UHFFFAOYSA-N Vasopressin Natural products N1C(=O)C(CC=2C=C(O)C=CC=2)NC(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CCCN=C(N)N)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C1CC1=CC=CC=C1 GXBMIBRIOWHPDT-UHFFFAOYSA-N 0.000 description 3
108010004977 Vasopressins Proteins 0.000 description 3
102000002852 Vasopressins Human genes 0.000 description 3
239000002253 acid Substances 0.000 description 3
KBZOIRJILGZLEJ-LGYYRGKSSA-N argipressin Chemical compound C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 KBZOIRJILGZLEJ-LGYYRGKSSA-N 0.000 description 3
230000004071 biological effect Effects 0.000 description 3
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
229960003726 vasopressin Drugs 0.000 description 3
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
239000005695 Ammonium acetate Substances 0.000 description 2
150000008574 D-amino acids Chemical group 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
230000001270 agonistic effect Effects 0.000 description 2
235000019257 ammonium acetate Nutrition 0.000 description 2
229940043376 ammonium acetate Drugs 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
238000006243 chemical reaction Methods 0.000 description 2
239000012043 crude product Substances 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
-1 octadecyl chain-modified silica gel Chemical class 0.000 description 2
229920001184 polypeptide Polymers 0.000 description 2
238000007363 ring formation reaction Methods 0.000 description 2
229910052708 sodium Inorganic materials 0.000 description 2
239000011734 sodium Substances 0.000 description 2
239000007858 starting material Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
230000003191 uterotonic effect Effects 0.000 description 2
210000004291 uterus Anatomy 0.000 description 2
ALBODLTZUXKBGZ-JUUVMNCLSA-N (2s)-2-amino-3-phenylpropanoic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCCCC[C@H](N)C(O)=O.OC(=O)[C@@H](N)CC1=CC=CC=C1 ALBODLTZUXKBGZ-JUUVMNCLSA-N 0.000 description 1
MLQKPYSHNONOFA-UHFFFAOYSA-N 2-[[2-[[2-[(2-nitrophenyl)sulfanylamino]acetyl]amino]acetyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)CNC(=O)CNSC1=CC=CC=C1[N+]([O-])=O MLQKPYSHNONOFA-UHFFFAOYSA-N 0.000 description 1
JMTMSDXUXJISAY-UHFFFAOYSA-N 2H-benzotriazol-4-ol Chemical compound OC1=CC=CC2=C1N=NN2 JMTMSDXUXJISAY-UHFFFAOYSA-N 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 1
HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000010933 acylation Effects 0.000 description 1
238000005917 acylation reaction Methods 0.000 description 1
230000004075 alteration Effects 0.000 description 1
239000011260 aqueous acid Substances 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
150000007942 carboxylates Chemical class 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000013078 crystal Substances 0.000 description 1
108700027018 deaminooxytocin Proteins 0.000 description 1
GTYWGUNQAMYZPF-QPLNMOKZSA-N demoxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSCCC(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 GTYWGUNQAMYZPF-QPLNMOKZSA-N 0.000 description 1
229960000477 demoxytocin Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000004108 freeze drying Methods 0.000 description 1
108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
230000003552 hormonogenic effect Effects 0.000 description 1
NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
238000005462 in vivo assay Methods 0.000 description 1
125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
JKRHDMPWBFBQDZ-UHFFFAOYSA-N n'-hexylmethanediimine Chemical compound CCCCCCN=C=N JKRHDMPWBFBQDZ-UHFFFAOYSA-N 0.000 description 1
MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 1
NMHMNPHRMNGLLB-UHFFFAOYSA-N phloretic acid Chemical compound OC(=O)CCC1=CC=C(O)C=C1 NMHMNPHRMNGLLB-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
230000001629 suppression Effects 0.000 description 1
125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Health & Medical Sciences (AREA)
Biochemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pyrrole Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NL8301663A 1982-05-10 1983-05-10 Analogen van neurohypofysiaire hormonen met remmende eigenschappen. NL8301663A (nl)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
CS823340A CS226923B1 (cs)	1982-05-10	1982-05-10	Analogy oxytocínu s inhibičnlm účinkem a způsob jejicb výroby
CS334082		1982-05-10
CS620582A CS229895B1 (cs)	1982-08-26	1982-08-26	Analog oxytocinu a způsob jeho výroby
CS620582		1982-08-26
CS620482		1982-08-26
CS620482A CS229894B1 (cs)	1982-08-26	1982-08-26	Analog vasopresinu a způsob jeho výroby
CS627182A CS230327B1 (en)	1982-08-27	1982-08-27	Oxytocine analogue and method of preparing same
CS627182		1982-08-27

Publications (1)

Publication Number	Publication Date
NL8301663A true NL8301663A (nl)	1983-12-01

Family

ID=27430101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL8301663A NL8301663A (nl)	1982-05-10	1983-05-10	Analogen van neurohypofysiaire hormonen met remmende eigenschappen.

Country Status (9)

Country	Link
BE (1)	BE896685A (da)
CH (1)	CH653346A5 (da)
DE (1)	DE3317092A1 (da)
DK (1)	DK199983A (da)
FR (1)	FR2526318B1 (da)
GB (1)	GB2121052B (da)
IT (1)	IT1164212B (da)
NL (1)	NL8301663A (da)
SE (1)	SE460051B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT398767B (de) *	1988-05-26	1995-01-25	Gebro Broschek Gmbh	Verfahren zur reinigung eines rohpeptids mittels präparativer mitteldruckflüssigkeitschromatographie
JP2003335797A (ja) *	2000-06-28	2003-11-28	Daicel Chem Ind Ltd	ペプチド化合物及びそれを有効成分とする医薬組成物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CS216722B1 (en) *	1980-06-24	1982-11-26	Michal Lebl	Oxytocine analogues and method of making the same

1983
- 1983-05-05 GB GB08312320A patent/GB2121052B/en not_active Expired
- 1983-05-05 DK DK199983A patent/DK199983A/da not_active Application Discontinuation
- 1983-05-06 BE BE0/210719A patent/BE896685A/fr not_active IP Right Cessation
- 1983-05-09 FR FR8307696A patent/FR2526318B1/fr not_active Expired
- 1983-05-09 SE SE8302643A patent/SE460051B/sv not_active IP Right Cessation
- 1983-05-09 IT IT21002/83A patent/IT1164212B/it active
- 1983-05-09 CH CH2530/83A patent/CH653346A5/de not_active IP Right Cessation
- 1983-05-10 NL NL8301663A patent/NL8301663A/nl not_active Application Discontinuation
- 1983-05-10 DE DE19833317092 patent/DE3317092A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
GB2121052B (en)	1985-08-14
GB8312320D0 (en)	1983-06-08
FR2526318A1 (fr)	1983-11-10
FR2526318B1 (fr)	1986-11-14
SE8302643D0 (sv)	1983-05-09
DK199983D0 (da)	1983-05-05
IT1164212B (it)	1987-04-08
SE8302643L (sv)	1983-11-11
CH653346A5 (de)	1985-12-31
DK199983A (da)	1983-11-11
DE3317092A1 (de)	1983-11-10
GB2121052A (en)	1983-12-14
SE460051B (sv)	1989-09-04
IT8321002A1 (it)	1984-11-09
IT8321002A0 (it)	1983-05-09
BE896685A (fr)	1983-09-01

Legal Events

Date	Code	Title
1985-01-01	A85	Still pending on 85-01-01
1990-03-01	BA	A request for search or an international-type search has been filed
1990-05-01	BB	A search report has been drawn up
1990-08-01	BC	A request for examination has been filed
1992-01-02	BV	The patent application has lapsed

Publication	Publication Date	Title
FI56676C (fi)	1980-03-10	Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller
CA1185235A (en)	1985-04-09	Antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin
Shao et al.	1995	Protein splicing: characterization of the aminosuccinimide residue at the carboxyl terminus of the excised intervening sequence
IE44426B1 (en)	1981-11-18	Polypeptide
US12162957B2 (en)	2024-12-10	Process for the preparation of plecanatide
SK118097A3 (en)	1998-04-08	Peptide and a method of obtaining it
EP0037516A1 (en)	1981-10-14	N-omega substituted derivatives of 1-Desamino-vasopressin analogs
US4543349A (en)	1985-09-24	Basic heptapeptide vasopressin antagonists
US4483794A (en)	1984-11-20	Analogs of neurohypophysial hormones
NL8301663A (nl)	1983-12-01	Analogen van neurohypofysiaire hormonen met remmende eigenschappen.
US4203975A (en)	1980-05-20	Psychopharmacological peptides suitable for therapeutic administration
LEBL et al.	1990	Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation
EP0135379B1 (en)	1988-04-20	Basic hexa- and hepta-peptide vasopressin antagonists
Lebl et al.	1985	Oxytocin analogues with inhibitory properties, containing in position 2 a hydrophobic amino acid of D-configuration
Chino et al.	1996	Generation of two isomers with the same disulfide connectivity during disulfide bond formation of human uroguanylin
Ten Kortenaar et al.	1985	Semisynthesis of horse heart cytochrome c analogues from two or three fragments.
EP0151016A2 (en)	1985-08-07	Arginine vasopressin antagonists
US4508645A (en)	1985-04-02	Analogs of neurohypophysial hormones with inhibition effects
US5618791A (en)	1997-04-08	Memory enhancing peptides
Procházka et al.	1992	Analogs of Deamino Carba Oxytocin with Inhibitory Properties; Synthesis and Biological Activities
Lebl et al.	1982	Analogues of neurohypophysial hormones, containing tert-leucine: Synthesis and properties
US4826813A (en)	1989-05-02	4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists
Zaoral et al.	1979	[1-β-Mercaptopropionic acid, 8-α-amino-β-guanidinopropionic acid] vasopressin and [1-β-mercaptopropionic acid, 8-D-α-amino-β-guanidinopropionic acid] vasopressin; Analogs showing a high and specific antidiuretic effect
Tomislav et al.	0	OXYTOCIN ANALOGUES WITH INHIBITORY PROPERTIES, CONTAINING IN POSITION 2 A HYDROPHOBIC AMINO ACID OF D-CONFIGURATION
US4749782A (en)	1988-06-07	Vasopressin compounds